SCHEMBL14655604

SCHEMBL14655604

O=C(O)c1c[nH]c2ncc(-c3cc(-n4cccc4)ccn3)nc12

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALK Q9UM73 1/20 0.37
SYK P43405 10/20 0.36
CYP2C9 P11712 1/20 0.36
JAK3 P52333 3/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
CYP2D6 P10635 2/20 0.35
KCNH2 Q12809 1/20 0.35
COMT P21964 1/20 0.34
AXL P30530 1/20 0.34
MRGPRX4 Q96LA9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14655572 0.86 ERCC1 (0.38) MAPK1SYKCYP2C9JAK3JAK2
SCHEMBL14655366 0.81 MAPK1 (0.47) MAPK1SYKCYP2C9JAK3JAK2
SCHEMBL14655368 0.78 AXL (0.47) MAPK1KDM4EPOLBSYKCYP2C9
SCHEMBL14655643 0.77 SORT1 (0.42) MAPK1ALDH1A1HPGDSYKCYP2C9
SCHEMBL14655425 0.77 CCR1 (0.47) MAPK1KDM4EALDH1A1POLBHPGD
SCHEMBL14655380 0.77 JAK3 (0.41) MAPK1SYKCYP2C9JAK3JAK2
SCHEMBL14655475 0.76 KDM4C (0.43) MAPK1KDM4ESYKCYP2C9JAK3
SCHEMBL12300102 0.76 JAK1 (0.45) JAK3JAK2JAK1
SCHEMBL14797172 0.75 PHF8 (0.50) MAPK1SYKJAK3JAK2JAK1
SCHEMBL14655364 0.75 MAPK1 (0.40) MAPK1KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8518945-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-08-27 US claimed
EP-2550273-A2 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 EP claimed
US-8518945-B2 Pyrrolopyrazine kinase inhibitors HOFFMANN-LA ROCHE INC. (US) 2013-08-27 US disclosed
EP-2550273-A2 PYRROLOPYRAZINE KINASE INHIBITORS F. Hoffmann-La Roche AG (CH) 2013-01-30 EP disclosed